This shows potential for Ozempic and other GLP1 receptor agonists as potential longevity drugs beyond their role as diabetes and obesity medication, and warrants more credibility to earlier claims that focused only on obese patients. Ref (5)
This shows potential for Ozempic and other GLP1 receptor agonists as potential longevity drugs beyond their role as diabetes and obesity medication, and warrants more credibility to earlier claims that focused only on obese patients. Ref (5)